Rivoglitazone Uses, Dosage, Side Effects and more
Rivoglitazone (INN) is a thiazolidinedione undergoing research for use in the treatment of type 2 diabetes. It is being developed by Daiichi Sankyo Co.
| Trade Name | Rivoglitazone |
| Generic | Rivoglitazone |
| Rivoglitazone Other Names | Rivoglitazone |
| Type | |
| Formula | C20H19N3O4S |
| Weight | Average: 397.45 Monoisotopic: 397.109627278 |
| Groups | Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
